Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years

Internal Medicine

Volumn 48, Issue 21, 2009, Pages 1919-1923

  Kobashi, Yoshihiro ^a   Shimizu, Hiroki ^a   Mouri, Keiji ^a   Irei, Tsutomu ^a   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Fluoro 2 deoxy D glucose (FDG) PET; Multiple bone metastases; Thymic carcinoid tumor

Indexed keywords

CHROMOGRANIN A; EPITHELIAL MEMBRANE ANTIGEN; FLUORODEOXYGLUCOSE; SYNAPTOPHYSIN;

AGED; ARTICLE; BONE BIOPSY; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOID; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW BACK PAIN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; THYMOMA; TUMOR RECURRENCE; TUMOR VOLUME;

AGED, 80 AND OVER; BIOPSY; BONE NEOPLASMS; CARCINOID TUMOR; FLUORODEOXYGLUCOSE F18; HUMANS; LUMBAR VERTEBRAE; MALE; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; THYMUS NEOPLASMS; TIME FACTORS;

EID: 71049183148     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2407     Document Type: Article

References (18)

1. Rosai I, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor: clinicopathologic study of 8 cases. Cancer 29: 1061-1074, 1972.
2. World Health Organization International Histological Classification of Tumors: Histological Typing of Lung and Pleural Tumors. 3rd ed. Travis WD, Colby TV, Corrins B, Shimosato Y, Brambilla E, Eds. Springer-Verlag, Berlin, 1999: 7-12.
3. Akiba T, Naruke T, Kondo H, et al. Carcinoid tumor of the lung: clinicopathological study of 32 cases. Jpn J Clin Oncol 22: 92-95, 1992.
4. Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstaw P. A clinocopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 124: 141-146, 2003. (Pubitemid 36851345)
5. Belhocine T, Foidart J, Rigo P, et al. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlation with the pathological indexes p53 and ki-67. Nucl Med Commun 23: 727-734, 2002. (Pubitemid 34837002)
6. Kaltsas G, Korbonits M, Heintz E, et al. Comparison of somatostatin analog and metaiodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 86: 895-902, 2001. (Pubitemid 32207512)
7. Zuetenhorst JM, Hefnageli CA, Boot H, Olmos RAV, Taal BG. Evaluation of 111In-pentetreotide, 131I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nucl Med Commun 23: 735-741, 2002. (Pubitemid 34837003)
8. Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG-PET. AJR Am J Roentgenol 170: 1369-1373, 1998. (Pubitemid 28210961)
9. de Montpreville VT, Macchiarini P, Dulmet E. Thymic neuroendocine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 111: 134-141, 1996. (Pubitemid 26035180)
10. 1]-octreotide. Acta Oncol 32: 783-786, 1993.
11. Kwekkenboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 20: 283-292, 1993. (Pubitemid 23233998)
12. Nocaudie-Calzada M, Huglo D, Carnaille B, Proye C, Marchandise X. Comparison of analogue and metaiodobezylguanidine scintigraphy for the detection of carcinoid tumors. Eur J Nucl Med 23: 1448-1454, 1996. (Pubitemid 26379185)
13. Meijer WG, Van der Veer E, Jager PL, et al. Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism. J Nucl Med 44: 184-191, 2003.
14. Le Rest C, Bomanji JB, Costa DC, Townsend CE, Visvikis D, Ell PJ. Functional imaging of malignant paragangliomas and carcinoid tumors. Eur J Nucl Med 28: 478-482, 2001. (Pubitemid 32260914)
15. Fujishita T, Kishida M, Taki H, et al. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D-glucose PET in a patient with thymic carcinoid. Respirology 12: 928-930, 2007. (Pubitemid 350045720)
16. Jadvar H, Segall GM. False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 38: 1382-1383, 1997. (Pubitemid 27386194)
17. Groves AM, Mohan HK, Wegner EA, Hain SF, Bingham JB, Clarke SE. Positron emission tomography with FDG to show thymic carcinoid. Am J Roentogenol 182: 511-513, 2004. (Pubitemid 38116602)
18. 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J Surg 22: 588-592, 1998.